Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_assertion type Assertion NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_head.
- NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_assertion description "[The percentages of MUC2-positive immunostaining for cystadenomas, borderline tumors, and cystadenocarcinomas were 0% (0/12), 50% (5/10), and 70% (7/10) respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_provenance.
- NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_assertion evidence source_evidence_literature NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_provenance.
- NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_assertion SIO_000772 10872659 NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_provenance.
- NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_assertion wasDerivedFrom befree-2016 NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_provenance.
- NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_assertion wasGeneratedBy ECO_0000203 NP287626.RA5thVbpPa2I7eRJXlAXxkzuu0SQs5DCQtSwGGcCUHhxY130_provenance.